Belgian Scientists Inhibit Protein Responsible For Allergic Reactions (ugent.be) 39
lhunath writes: Scientists at the University of Gent exposed the TSLP protein's function in triggering allergic reactions such as asthma and eczema. The team then developed a protein-based inhibitor used to capture TSLP and prevent its bioactivity as it associates with its natural receptors. Using this method, allergic reactions can be inhibited before they are triggered.
The team's results were recently published in Nature, where they share a vision that their work "will guide therapeutic approaches that manipulate human TSLP-mediated signalling to treat allergic diseases."
The team's results were recently published in Nature, where they share a vision that their work "will guide therapeutic approaches that manipulate human TSLP-mediated signalling to treat allergic diseases."
Coming soon (Score:1)
Re:Coming soon (Score:5, Funny)
It was discovered by a university, not a commercial drug lab. Either way, this is nothing to sneeze at.
Re: (Score:3)
I'm itching to give it a try.
Re: (Score:2)
But only if I can get up the scratch.
Re: (Score:2)
This news is so exciting, I can barely breathe.
No, seriously, I have activity-induced bronchial asthma.
Re: (Score:3)
Re:Coming soon (Score:4, Informative)
Re: (Score:3)
Nah, it looks like it will be a monoclonal antibody, so only around $10,000 per monthly infusion. That's the going rate for drugs that end in "umab" which is apparently latin for 'expensive'.
Anyway, thanks for the real link, editors.
Re:Coming soon (Score:4, Interesting)
Re: (Score:2)
Only $5000. Per pill.
Americans will have to wait until it goes off patent. Then it will be marked up to $6000 per pill by whoever is able to game the FDA import regs, but we will then be able to smuggle in the generic version at its low world price.
Allergies (Score:2)
Re: (Score:3)
This doesn't sound like a cure so much as a treatment. That one has to take on a regular basis. For the rest of one's life.
Should a product come to market, most healthplans won't cover it for most cases, only the most severe relevant allergic reactions that have strong chance in resulting in death of the patient would be covered. Expect a rise in the number of Athsma diagnoses.
Re: (Score:2)
A lot of the serious issues caused by the immune system in childhood involve using dangerous drugs like methotrexate to stop the process and restart it. If there could be a more effective and safe treatment that would be awesome. Again, maybe not available in the US though.
Re: (Score:3)
And you know this how, exactly?
And you know this how, exactly?
Re: (Score:2)
Re: (Score:1)
A cure would likely need gene revision or modification. Yes, it's a treatment. But if it turns out to yield a useable drug, it will sit on the shelf with a long line of 'biologics'. These are usually monoclonal antibodies [wikipedia.org] (think Humira [wikipedia.org]) and have been successfully used to treat a number of typically autoimmune diseases. They're harder to make than small molecule drugs and the biochemistry is pretty damned complex (read TFA if you can), so they're going to be more expensive than your typical bulk chemical
Re: (Score:2)
Re: (Score:1)
I'm allergic to my own sweat. Literally, not as an excuse to be lazy. It affects every moment of my life. I toss and turn at night, scratching my skin into a bloody mess. I can't go outside during the summer. It's miserable. Research like this gives me hope. I'm tired of waking up with my scabs having fused with my bedsheets. I know that's graphic, but it's a very real example of the kind of problem these drugs can solve. So far nothing helps except for predisone, which isn't a long term solution (lots of n
Re: (Score:2)
Re: (Score:3)
Nope. Survival of the fittest will always be the rule. It just happens that, at this point in time, 'fittest' means those humans closely attached to a complex, highly developed society that can make 747's, moon rockets and wildly complex drugs have a distinct advantage over previous humans and those unfortunates that live in New Jersey.
This may change at some point in the future.....
Re: (Score:2)
Exciting! (Score:4, Insightful)
Re: (Score:2)
The problem is allergies are problems with the fine-tuning of the immune system. Anything which massively inhibits this is going to cause massive problems...perhaps up to the "bubble-boy syndrome" level.
OTOH, I can't tell from the summary, but this might be something that eliminated immune response against some particular (set of?) proteins. That might be really impressive and useful. But it would also need to be tuned to particular allergens that were to be considered "not dangerous". So you'd need a l
Re: (Score:3)
The problem is allergies are problems with the fine-tuning of the immune system. Anything which massively inhibits this is going to cause massive problems...perhaps up to the "bubble-boy syndrome" level.
It depends on which subset you're talking about when you say "allergies".
The common sniffiling-and-hives branch is apparently a rapid massive-response to attack tropical worms,. You get "allergies" when this bored system decides that molecule on a plant pollen grain or some other irritant is actually a trop
Re: (Score:3)
You are exactly right with the following two lines:
"The problem is allergies are problems with the fine-tuning of the immune system."
"Otherwise this is a bit of highly important research, but it won't lead directly to anything usefully applicable"
As a better understanding of our immune system, and how we can help fine tune it, will have tremendous impact on disease research and finding treatment procedures.
Allergy issues are increasing and so is the complexity of cancer, and they would both benefit from of
The scientists were promptly assassinated (Score:2)
No *all* allergies (Score:5, Informative)
This won't prevent all allergic responses. We've carried out research that indicates there are at least two types of allergic responses, one TSLP-dependent and another Interferon alpha-dependent:
https://growkudos.com/publicat... [growkudos.com]
The TSLP response seems to be most associated with chemical-related irritants (e.g. cinnamon oil, SLS), while the IFN-a response seems to be most associated with small organism irritants (e.g. house dust mites, parasites).